Akba stock price forecast investor sentiment indicators currently

Investor sentiment indicators currently lean neutral-to-positive on akba stock price forecast, but news flow will remain the determining factor. We note that hedge funds don't have a meaningful investment in Akebia Therapeutics. The company's largest shareholder is BlackRock, Inc., with ownership of 6.9%. With 5.5% and 3.0% of the shares outstanding respectively, The Vanguard Group, Inc. and State Street Global Advisors, Inc. are the second and third largest shareholders. In addition, we found that John Butler, the CEO has 0.6% of the shares allocated to their name. Lilly beat estimates in each of the last four quarters, delivering a four-quarter average earnings surprise of 69.07%. Some day traders eye akba stock price forecast as speculative swing trade material, citing favorable risk-reward ratios around current support levels.